Accentia drug first aimed at 'curing' MS
UPI Tue, 31 Jul 2007 10:48 AM PDT
U.S. firm Accentia Biopharmaceuticals said Tuesday it is seeking the go-ahead for phase 3 testing of Revimmune, aimed at reversing multiple sclerosis.
New multiple sclerosis gene identified
New Scientist Wed, 01 Aug 2007 10:08 AM PDT
A new gene variant that increases the risk of MS by 20 to 30 per cent is identified after 30 years of searching

2 Genes Discovered for Multiple Sclerosis
WLNS Lansing Wed, 01 Aug 2007 6:13 AM PDT
Researchers create genetic roadmap.

Misfiring nervous system makes heart beat faster
Detroit News Tue, 31 Jul 2007 11:24 PM PDT
Dear Dr. Donohue: After multiple tests and visits to neurologists for symptoms similar to multiple sclerosis, one doctor finally recognized in our daughter the characteristics of postural orthostatic tachycardia syndrome -- POTS. She now sees a doctor who specializes in this disorder. Many others have told her that they too have the illness but suffered terribly until they obtained the correct ...

Palliative Care for Patients With Amyotrophic Lateral Sclerosis ...
Journal of American Medical Association (subscription) - Chicago,IL,USA
... riluzole, extends life by about 2 months. Virtually all skeletal muscles eventually are affected. Multiple problems require a multidisciplinary approach ...
See all stories on this topic

Multiple sclerosis linked to gene variants
Akron Beacon Journal - Akron,OH,USA
Scientists at the US National Institutes of Health are testing Roche's Zenapax, which blocks the interleukin-7 receptor, in multiple sclerosis, ...
See all stories on this topic

Understanding the Causes of Amyotrophic Lateral Sclerosis
New England Journal of Medicine (subscription) - MA,USA
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007;1:CD001447-CD001447. ...
See all stories on this topic